J. C. Betts, M. R. Edbrooke, R. Thakker, and P. Woo, The Human Acute-Phase Serum Amyloid A Gene Family: Structure, Evolution and Expression in Hepatoma Cells, Scand J Immunol, vol.34, issue.4, p.1656519, 1991.

D. M. Steel, G. C. Sellar, C. M. Uhlar, S. Simon, F. C. Debeer et al., A constitutively expressed Serum amyloid A protein gene (SAA4) is closely linked to, and shares structural similarities with, an acute-phase Serum amyloid A protein gene (SAA2), Genomics, vol.16, issue.2, p.7686132, 1993.

L. Sun and R. D. Ye, Serum amyloid A1: Structure, function and gene polymorphism, Gene, vol.583, issue.1, p.26945629, 2016.
DOI : 10.1016/j.gene.2016.02.044

URL : http://europepmc.org/articles/pmc5683722?pdf=render

C. M. Uhlar and A. S. Whitehead, Serum amyloid A, the major vertebrate acute-phase reactant, Eur J Biochem, vol.265, issue.2, p.10504381, 1999.

B. Kluve-beckerman, M. L. Drumm, and M. D. Benson, Nonexpression of the human serum amyloid A three (SAA3) gene, DNA Cell Biol, vol.10, issue.9, p.1755958, 1991.

M. A. Larson, S. H. Wei, A. Weber, A. T. Weber, and T. L. Mcdonald, Induction of human mammary-associated serum amyloid A3 expression by prolactin or lipopolysaccharide, Biochem Biophys Res Commun, vol.301, issue.4, p.12589816, 2003.

C. M. Uhlar, C. J. Burgess, P. M. Sharp, and A. S. Whitehead, Evolution of the serum amyloid A (SAA) protein superfamily, Genomics, vol.19, issue.2, p.8188253, 1994.

R. D. Ye and L. Sun, Emerging functions of serum amyloid A in inflammation, J Leukoc Biol, vol.98, issue.6, p.26130702, 2015.

G. Marhaug and S. B. Dowton, Serum amyloid A: an acute phase apolipoprotein and precursor of AA amyloid, Baillieres Clin Rheumatol, vol.8, issue.3, p.7525085, 1994.

D. Buck, M. Gouwy, M. Wang, J. Snick, J. Opdenakker et al., Structure and expression of different serum amyloid A (SAA) variants and their concentration-dependent functions during host insults, Curr Med Chem, vol.23, issue.17, p.27087246, 2016.

D. Buck, M. Gouwy, M. Wang, J. M. Van-snick, J. Proost et al., The cytokine-serum amyloid Achemokine network, Cytokine Growth Factor Rev, vol.30, p.26794452, 2016.

C. L. Banka, T. Yuan, . Beer-mc-de, M. Kindy, L. K. Curtiss et al., Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux, J Lipid Res, vol.36, issue.5, p.7658153, 1995.

E. P. Benditt and N. Eriksen, Amyloid protein SAA is associated with high density lipoprotein from human serum, Proc Natl Acad Sci, vol.74, issue.9, pp.4025-4033, 1977.

G. A. Coetzee, A. F. Strachan, D. R. Van-der-westhuyzen, H. C. Hoppe, M. S. Jeenah et al., Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition, J Biol Chem, vol.261, issue.21, p.3525531, 1986.

N. M. Frame and O. Gursky, Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks, FEBS Lett, vol.590, issue.6, p.26918388, 2016.

C. Y. Han, C. Tang, M. E. Guevara, H. Wei, T. Wietecha et al., Serum amyloid A impairs the antiinflammatory properties of HDL, J Clin Invest, vol.126, issue.1, pp.266-81, 2016.

B. Kluve-beckerman, J. Manaloor, and J. J. Liepnieks, Binding, trafficking and accumulation of serum amyloid A in peritoneal macrophages, Scand J Immunol, vol.53, issue.4, 2001.

J. J. Liepnieks, B. Kluve-beckerman, and M. D. Benson, Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1, Biochim Biophys Acta, vol.1270, issue.1, p.7827140, 1995.

D. Buck, M. Berghmans, N. Pö-rtner, N. Vanbrabant, L. Cockx et al., Serum amyloid A1? induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils, J Leukoc Biol, vol.98, issue.6, p.26297794, 2015.

K. K. Eklund, K. Niemi, and P. T. Kovanen, Immune functions of serum amyloid A, Crit Rev Immunol, vol.32, issue.4, p.23237509, 2012.

M. Gouwy, D. Buck, M. Pö-rtner, N. Opdenakker, G. Proost et al., Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines, Eur J Immunol, vol.45, issue.1, p.25345597, 2015.

D. Santo, C. Arscott, R. Booth, S. Karydis, I. Jones et al., Invariant NKT cells modulate the suppressive activity of Serum Amyloid A-differentiated IL-10-secreting neutrophils, Nat Immunol, vol.11, issue.11, p.20890286, 2010.

L. Sun, H. Zhou, Z. Zhu, Q. Yan, L. Wang et al., Ex vivo and in vitro effect of Serum Amyloid A in the induction of macrophage M2 markers and efferocytosis of apoptotic neutrophils, J Immunol, vol.194, issue.10, p.25870242, 2015.

I. N. Baranova, T. G. Vishnyakova, A. V. Bocharov, R. Kurlander, Z. Chen et al., Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases, J Biol Chem, vol.280, issue.9, p.15576377, 2005.

N. Cheng, R. He, J. Tian, P. P. Ye, and R. D. Ye, Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A, J Immunol, vol.181, issue.1, p.18566366, 2008.

S. Sandri, D. Rodriguez, E. Gomes, H. P. Monteiro, M. Russo et al., Is serum amyloid A an endogenous TLR4 agonist?, J Leukoc Biol, vol.83, issue.5, p.18252871, 2008.

G. Lopalco, O. M. Lucherini, A. Vitale, R. Talarico, A. Lopalco et al., Putative role of Serum Amyloid-A and proinflammatory cytokines as biomarkers for Behcet's disease. Medicine (Baltimore), vol.94, p.1858, 2015.

O. M. Lucherini, G. Lopalco, L. Cantarini, G. Emmi, A. Lopalco et al., Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease, Immunol Lett, vol.201, p.30385329, 2018.

E. S. Chen, Z. Song, M. H. Willett, S. Heine, R. C. Yung et al., Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med, vol.181, pp.360-73, 2010.

G. H. Sack, Serum amyloid A-a review, Mol Med, vol.24, issue.1, 2018.

C. F. Thorn and A. S. Whitehead, Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase Serum amyloid A genes, SAA1 and SAA2, J Immunol, vol.169, issue.1, p.12077270, 2002.

C. F. Thorn, Z. Lu, and A. S. Whitehead, Regulation of the human acute phase serum amyloid A genes by Tumour Necrosis Factor-?, Interleukin-6 and glucocorticoids in hepatic and epithelial cell lines, Scand J Immunol, vol.59, issue.2, p.14871291, 2004.

S. Urieli-shoval, P. Cohen, S. Eisenberg, and Y. Matzner, Widespread expression of serum amyloid A in histologically normal human tissues: predominant localization to the epithelium, J Histochem Cytochem, vol.46, issue.12, p.9815279, 1998.

Y. Kumon, T. Suehiro, K. Hashimoto, and J. D. Sipe, Dexamethasone, but not IL-1 alone, upregulates acutephase serum amyloid A gene expression and production by cultured human aortic smooth muscle cells, Scand J Immunol, vol.53, issue.1, p.11169201, 2001.

R. L. Meek, S. Urieli-shoval, and E. P. Benditt, Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function, Proc Natl Acad Sci, vol.91, issue.8, p.8159722, 1994.

N. Upragarin, W. Landman, W. Gaastra, and E. Gruys, Extrahepatic production of acute phase serum amyloid A, Histol Histopathol, vol.20, issue.4, p.16136510, 2005.

R. O'hara, E. P. Murphy, A. S. Whitehead, O. Fitzgerald, and B. Bresnihan, Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue, Arthritis Res, vol.2, issue.2, p.11062604, 2000.

R. Vallon, F. Freuler, N. Desta-tsedu, A. Robeva, J. Dawson et al., Serum Amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of Matrix Metalloproteinases, J Immunol, vol.166, issue.4, p.11160347, 2001.

E. S. Chen and D. R. Moller, Etiologies of sarcoidosis, Clin Rev Allergy Immunol, vol.49, issue.1, p.25771769, 2015.

A. Huho, L. Foulke, T. Jennings, E. Koutroumpakis, S. Dalvi et al., The role of serum amyloid A staining of granulomatous tissues for the diagnosis of sarcoidosis, Respir Med, vol.126, p.28427539, 2017.

K. C. Patterson and E. S. Chen, The pathogenesis of pulmonary sarcoidosis and implications for treatment, Chest, vol.153, issue.6, p.29224832, 2018.

S. Bozinovski, M. Uddin, R. Vlahos, M. Thompson, J. L. Mcqualter et al., Serum amyloid A opposes lipoxin A to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease, Proc Natl Acad Sci, vol.109, issue.3, p.22215599, 2012.

S. Urieli-shoval, R. L. Meek, R. H. Hanson, N. Eriksen, and E. P. Benditt, Human serum amyloid A genes are expressed in monocyte/macrophage cell lines, Am J Pathol, vol.145, issue.3, p.8080047, 1994.

T. Yamada, T. Kakihara, T. Kamishima, T. Fukuda, and T. Kawai, Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions, Pathol Int, vol.46, issue.10, p.8916152, 1996.

Y. Wada and I. Igari, Serum Amyloid A secretion from monocytic leukaemia cell line THP-1 and cultured human peripheral monocytes, Scand J Immunol, vol.52, issue.1, p.10886778, 2000.

R. L. Meek, N. Eriksen, and E. P. Benditt, Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages, Proc Natl Acad Sci, vol.89, issue.17, p.1518819, 1992.

S. Pé-gorier, D. Stengel, H. Durand, M. Croset, and E. Ninio, Oxidized phospholipid: POVPC binds to plateletactivating-factor receptor on human macrophages. Implications in atherosclerosis, Atherosclerosis, vol.188, issue.2, p.16386258, 2006.

F. Awad, E. Assrawi, C. Jumeau, S. Georgin-lavialle, L. Cobret et al., Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation, PLoS ONE, vol.12, issue.4, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01509838

D. Berrebi, S. Bruscoli, N. Cohen, A. Foussat, G. Migliorati et al., Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood, Jan, vol.15, issue.2, p.12393603, 2003.

J. F. Bernaudin, K. Yamauchi, M. D. Wewers, M. J. Tocci, V. J. Ferrans et al., Demonstration by in situ hybridization of dissimilar IL-1 beta gene expression in human alveolar macrophages and blood monocytes in response to lipopolysaccharide, J Immunol, vol.140, issue.11, p.3259599, 1988.

D. R. Bainton and D. W. Golde, Differentiation of macrophages from normal human bone marrow in liquid culture. Electron microscopy and cytochemistry, J Clin Invest, vol.61, issue.6, p.659615, 1978.

Z. A. Cohn and B. Benson, The differentiation of mononuclear phagocytes: morphology, cytochemistry, and biochemistry, J Exp Med, vol.121, issue.1, pp.153-70, 1965.

E. Couderc, F. Morel, P. Levillain, A. Buffière-morgado, M. Camus et al., Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis, PLoS ONE, vol.12, issue.7, p.28708859, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01703911

J. M. Busillo and J. A. Cidlowski, The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore, Trends Endocrinol Metab, vol.24, issue.3, p.23312823, 2013.

I. Beck, W. Van-den-berghe, L. Vermeulen, K. R. Yamamoto, G. Haegeman et al., Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases, Endocr Rev, vol.30, issue.7, pp.830-82, 2009.

Y. Chinenov and I. Rogatsky, Glucocorticoids and the innate immune system: crosstalk with the Toll-like receptor signaling network, Mol Cell Endocrinol, vol.275, issue.1, pp.30-42, 2007.

M. A. Hermoso, T. Matsuguchi, K. Smoak, and J. A. Cidlowski, Glucocorticoids and Tumor Necrosis Factor alpha cooperatively regulate Toll-like receptor 2 gene expression, Mol Cell Biol, vol.24, issue.11, p.15143169, 2004.

E. A. Lannan, A. J. Galliher-beckley, A. B. Scoltock, and J. A. Cidlowski, Proinflammatory actions of glucocorticoids: glucocorticoids and TNF? coregulate gene expression in vitro and in vivo, Endocrinology, 2012.

, Aug, vol.1, issue.8, p.22673229

M. Guha and N. Mackman, LPS induction of gene expression in human monocytes, Cell Signal, vol.13, issue.2, p.11257452, 2001.

. Mackman, K. Brand, and T. S. Edgington, Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites, J Exp Med, vol.174, issue.6, p.1744583, 1991.

S. Natsuka, S. Akira, Y. Nishio, S. Hashimoto, T. Sugita et al., Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6, Blood, vol.79, issue.2, p.1730090, 1992.

A. N. Shakhov, M. A. Collart, P. Vassalli, S. A. Nedospasov, and C. V. Jongeneel, Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages, J Exp Med, vol.171, issue.1, p.2104921, 1990.

S. Ghosh, M. J. May, and E. B. Kopp, NF-?B AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses, Annu Rev Immunol, vol.16, issue.1, pp.225-60, 1998.

V. Poli, The role of C/EBP isoforms in the control of inflammatory and native immunity functions, J Biol Chem, vol.273, issue.45, p.9792624, 1998.

E. Ayroldi and C. Riccardi, Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action, FASEB J, vol.23, issue.11, p.19567371, 2009.

P. J. Barnes, Anti-inflammatory actions of glucocorticoids: molecular mechanisms, Clin Sci, vol.94, issue.6, p.9854452, 1998.

N. Rao, M. T. Mccalman, P. Moulos, K. Francoijs, A. Chatziioannou et al., Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes, Genome Res, vol.21, issue.9, p.21750107, 2011.

D. W. Cain and J. A. Cidlowski, Immune regulation by glucocorticoids, Nat Rev Immunol, vol.17, p.28192415, 2017.

E. M. King, J. E. Chivers, C. F. Rider, A. Minnich, M. A. Giembycz et al., Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation-and transrepression-dependent mechanisms, PLoS ONE, vol.8, issue.1, p.23349769, 2013.

W. Ishii, J. J. Liepnieks, T. Yamada, M. D. Benson, and B. Kluve-beckerman, Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium, Amyloid, vol.20, issue.2, p.23461622, 2013.

S. L. Jiang, D. Samols, D. Rzewnicki, S. S. Macintyre, I. Greber et al., Kinetic modeling and mathematical analysis indicate that acute phase gene expression in Hep 3B cells is regulated by both transcriptional and posttranscriptional mechanisms, J Clin Invest, vol.95, issue.3, p.7883974, 1995.

D. Valeyre, A. Prasse, H. Nunes, Y. Uzunhan, P. Brillet et al., The Lancet, vol.383, pp.1155-67, 2014.

P. Soler, F. Basset, J. F. Bernaudin, and J. Chretien, Morphology and distribution of the cells of a sarcoid granuloma: ultrastructural study of serial sections, Ann N Y Acad Sci, vol.278, issue.1, pp.147-60, 1976.

E. S. Chen and D. R. Moller, Sarcoidosis-scientific progress and clinical challenges, Nat Rev Rheumatol, vol.7, issue.8, p.21750528, 2011.

D. Anthony, J. L. Mcqualter, M. Bishara, E. X. Lim, S. Yatmaz et al., SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling, FASEB J, vol.28, issue.9, p.24846388, 2014.

A. Beringer and P. Miossec, IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases, Autoimmun Rev, vol.17, issue.12, p.30321671, 2018.